SHOULDER INNOVATIONS, INC. (SI) Stock

SHOULDER INNOVATIONS, INC. (SI) is a Healthcare stock trading at $18.57 (as of 2026-06-18), with a market capitalization of $304.85M and a trailing P/E of 0.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Shoulder Innovations, Inc. (SI) manufactures medical devices and has developed a shoulder replacement system. Founded in 2009 and based in Grand Rapids, Michigan, the company’s products are used to support care related to shoulder replacement.

Valuation — source: SEC EDGAR (first-party)
Price$18.57
Market Cap$304.85M
P/E Ratio0.3
EV / EBITDA-11.2
Price / Book2.29
Price / Sales5.66
DCF Value (model)$-29.12
DCF Upside vs Price-256.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$47.32M
Net Margin-85.3%
Return on Equity-33.1%
Debt / Equity0.11
Current Ratio11.81
Revenue Growth (YoY)49.6%
EPS Growth (YoY)-98.1%
FCF Growth (YoY)98.4%
Financial Health — source: SEC EDGAR
Altman Z-Score7.87 (safe)
Valuation vs Sector & Industry
Stock P/E0.3
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-98.5%
vs Industry-99.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFMR LLC ($54.99M)
Institutional Holders Tracked10
Congressional Trades (recent)4
Company
SectorHealthcare
IndustryMedical Equipment
CEOAlan J. Lane
Employees300
CountryUS
IPO Date2025-07-31

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Delcath Systems, Inc. (DCTH)
  • CARLSMED, INC. (CARL)
  • Quanterix Corporation (QTRX)
  • Profound Medical Corp. (PROF)
  • KORU Medical Systems, Inc. (KRMD)
  • SANUWAVE Health, Inc. (SNWV)
  • Nautilus Biotechnology, Inc. (NAUT)
  • Geospace Technologies Corporation (GEOS)
SI earnings history · SI institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.